Comparison of antimicrobial resistance phenotypes and resistance genes in Enterococcus faecalis and Enterococcus faecium from humans in the community, broilers, and pigs in Denmark

Diagnostic Microbiology and Infectious Disease

Volumn 37, Issue 2, 2000, Pages 127-137

  Aarestrup, F M ^a   Agerso, Y ^a   Gerner Smidt, P ^b   Madsen, M ^a   Jensen, L B ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AVILAMYCIN; BACITRACIN; CHLORAMPHENICOL; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; GENTAMICIN; KANAMYCIN; MACROLIDE; PENICILLIN G; STREPTOMYCIN; TETRACYCLINE; UNCLASSIFIED DRUG; VANCOMYCIN; VIRGINIAMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CHICKEN; DENMARK; DISEASE TRANSMISSION; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FECES ANALYSIS; GENOTYPE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SWINE;

EID: 0034116911     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(00)00130-9     Document Type: Article

References (80)

1. Aarestrup F.M., Ahrens P., Madsen M., Pallesen L.V., Poulsen R.L., Westh H. Glycopeptide susceptibility among Danish Enterococcus faecium and Enterococcus faecalis isolates of animal and human origin and PCR identification of genes within the VanA cluster. Antimicrob Agents Chemother. 40:1996;1938-1940.
2. Aarestrup F.M., Bager F., Jensen N.E., Madsen M., Meyling A., Wegener H.C. Surveillance of antimicrobial resistance in bacteria isolated from food animals to antimicrobial growth promoters and related therapeutic agents in Denmark. APMIS. 106:1998;606-622.
3. Aarestrup F.M., Bager F., Jensen N.E., Madsen M., Meyling A., Wegener H.C. Resistance to antimicrobial agents used for animal therapy in pathogenic-, zoonotic-, and indicator bacteria isolated from different food animals in Denmark a baseline study for the Danish Integrated Antimicrobial Resistance Monitoring Programme (DANMAP) . APMIS. 106:1998;745-770.
4. Aarestrup F.M. Association between the consumption of antimicrobial agents in animal husbandry and the occurrence of resistant bacteria among food animals. Int J Antimicrob Agents. 12:1999;279-285.
5. van Asselt G.J., Vliegenthart J.S., Petit P.L.C., van de Kludert J.A.M., Mouton R.P. High-level aminoglycoside resistance among enterococci and group A streptococci. J Antimicrob Chemother. 30:1992;651-659.
6. Atkinson B.A., Abu-Al-Jaibat A., LeBlanc D.J. Antibiotic resistance among enterococci isolated from clinical specimens between 1953 and 1954. Antimicrob Agents Chemother. 41:1997;1598-1600.
7. van der Auwera P., Pensart N., Korten V., Murray B. Influence of oral glycopeptides on the fecal flora of human volunteers selection of highly glycopeptide resistant enterococci . J Infect Dis. 173:1996;1129-1136.
8. Bager F., Madsen M., Christensen J., Aarestrup F.M. Avoparcin used as a growth promoter is associated with the occurrence of vancomycin-resistant Enterococcus faecium on Danish poultry and pig farms. Prev Vet Med. 31:1997;95-112.
9. Bager F., Aarestrup F.M., Madsen M., Wegener H.C. Levels of glycopeptide resistant E. faecium in broilers and pigs following ban on the use of avoparcin. Microb Drug Resist. 5:1999;53-56.
10. Bates J., Jordens Z., Griffiths D.T. Farm animals as a putative reservoir for vancomycin resistant enterococcal infection in man. J Antimicrob Chemother. 34:1994;507-516.
11. Bentorcha F., De Cespedes G., Horaud T. Tetracycline resistance heterogeneity in Enterococcus faecium. Antimicrob Agents Chemother. 35:1991;808-812.
12. van den Bogaard A.E., Jensen L.B., Stobberingh E.E. Vancomycin-resistant enterococci in turkeys and farmers. N Engl J Med. 337:1997;1558-1559.
13. Bonafede M.E., Carias L.L., Rice L.B. Enterococcal transposon Tn 5384, Evolution of a composite transposon through cointegration of enterococcal and staphylococcal plasmids. Antimicrob Agents Chemother. 41:1997;1854-1858.
14. Charpentier E., Gerbaud G., Courvalin P. Presence of the Listeria tetracycline resistance gene tet(S) in Enterococcus faecalis. Antimicrob Agents Chemother. 38:1994;2330-2335.
15. Chen H.Y., Williams J.D. Transferable resistance and aminoglycoside-modifying enzymes in enterococci. J Med Microbiol. 20:1985;187-196.
16. Clewell D.B., Gawron-Burke C. Conjugative transposons and the dissemination of antibiotic resistance in streptococci. Ann Rev Microbiol. 40:1986;635-659.
17. Clewell D.B., Flannagan S.E., Jaworski D.D. Unconstrained bacterial promiscuity the Tn916-Tn1545 family of conjugative transposons . Trends Microbiol. 3:1995;229-236.
18. Cockerill, III, F. R. (1999). Genetic methods for assessing antimicrobial resistance. Antimicrob Agents Chemother, 43, 199-212.
19. Coque T.M., Arduino R.C., Murray B.E. High-level resistance to aminoglycosides comparison of community and nosocomal fecal isolates of enterococci . Clin Infect Dis. 20:1995;1048-1051.
20. Dutta G.N., Devriese L.A. Susceptibility of fecal streptococci of poultry origin to nine growth-promoting agents. Appl Environ Microbiol. 44:1982;832-837.
21. Endtz H.P., van den Braak N., van Belkum A., Kluytmans J.A., Koeleman J.G., Spanjaard L., Voss A., Weersink A.J., Vandenbroucke-Grauls C.M., Buiting A.G., van Duin A., Verbrugh H.A. Fecal carriage of vancomycin-resistant enterococci in hospitalized patients and those living in the community in The Netherlands. J Clin Microbiol. 35:1997;3026-3031.
22. Facklam, R. R., Sahm, D. F., & Teixeira, L. M. (1999). Enterococcus. In: Murray, P. R. (Ed.), Manual of Clinical Microbiology. American Society for Microbiology, Washington D.C., 297-305.
23. Ferretti J.J., Gilmore K.S., Courvalin P. Nucleotide sequence analysis of the gene specifying the bifunctional 6′-aminoglycoside acetyltransferase 2-aminoglycoside phosphotransferase enzyme in Streptococcus faecalis and identification and cloning of gene regions specifying the two activities. J Bacteriol. 167:1986;631-638.
24. Fletcher H.M., Marri L., Daneo-Moore L. Transposon-916-like elements in clinical isolates of Enterococcus faecium. J Gen Microbiol. 135:1989;3067-3077.
25. Franke A.E., Clewell D.B. Evidence for a chromosome-borne resistance transposon (Tn 916) in Streptococcus faecalis that is capable of "conjugal" transfer in the absence of a conjugative plasmid. J Bacteriol. 45:1981;494-502.
26. Gordon, S., Swenson, J. M., Hill, B. C., Pigott, N. E., Facklam, R. R., Cooksey, R. C., Thornsberry, C., Enterococcal Study Group, Jarvis, W. R., & Tenover, F. C. (1992). Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States. J Clin Microbiol, 30, 2373-2378.
27. Hammerum A.M., Jensen L.B., Aarestrup F.M. Detection of the satA gene and transferability of virginiamycin resistance in Enterococcus faecium from food-animals. FEMS Microbiol Lett. 168:1998;145-151.
28. Horaud T., Delbos F., de Cespedes G. Tn3702, a conjugative transposon in Enterococcus faecalis. FEMS Microbiol Lett. 60:1990;189-194.
29. Iwen P.C., Kelly D.M., Linder J., Hinrichs S.H., Dominguez E.A., Rupp M.E., Patil K.D. Change in prevalence and antibiotic resistance of Enterococcus species isolated from blood cultures over an 8-year period. Antimicrob Agent Chemother. 41:1997;494-495.
30. Jensen L.B., Ahrens P., Dons L., Jones R.N., Hammerum A., Aarestrup F.M. Molecular analysis of the Tn 1546 in Enterococcus faecium isolated from animals and humans. J Clin Microbiol. 36:1998;437-442.
31. Jensen L.B., Frimodt-Møller N., Aarestrup F.M. Prevalence of the erm genes in gram positive bacterial spp. of animal and human origin. FEMS Microbiol Lett. 170:1999;151-158.
32. Jones R.N., Ballow C.H., Biedenbach D.J., Deinhart J.A., Schentag J.J. Antimicrobial activity of quinupristin-dalfopristin (RP 59500, Synercid) tested against over 28,000 recent clinical isolates from 200 medical centers in the U.S. and Canada. Diagn Microbiol Infect Dis. 31:1998;437-451.
33. Jordens Z., Bates J., Griffiths D.T. Fecal carriage and nosocomial spread of vancomycin resistant Enterococcus faecium. J Antimicrob Chemother. 34:1994;515-528.
34. Kang, S. L., & Rybak, M. J. (1997). In-vitro bactericidal activity of quinupristin/dalfopristin alone and in combination against resistant strains of Enterococcus species and Staphylococcus aureus. J Antimicrob Chemother 39, Suppl A: 33-39.
35. Kaufhold A., Podbielski A., Horaud T., Ferrieri P. Identical genes confer high-level resistance to gentamicin upon Enterococcus faecalis, Enterococcus faecium, and Streptococcus agalactiae. Antimicrob Agents Chemother. 36:1992;1215-1218.
36. Klare I., Heier H., Claus H., Reissbrodt R., Witte W. van. A-mediated high-level glycopeptide resistance in Enterococcus faecium from animal husbandry. FEMS Microbiol Lett. 125:1995;165-172.
37. Klare I., Claus H., Böhme G., Marin S., Seltmann G., Hakenbeck R., Antanassova V., Witte W. Enterococcus faecium. strains with vanA-mediated high-level glycopeptide resistance isolated from animal foodstuffs and fecal samples of humans in the community. Microb Drug Res. 1:1995;265-272.
38. Klein G., Pack A., Reuter G. Antibiotic resistance patterns of enterococci and occurrence of vancomycin-resistant enterococci in raw minced beef and pork in Germany. Appl Environ Microbiol. 64:1998;1825-1830.
39. LeBlanc D.J., Inamine J.M., Lee L.N. Broad geographical distribution of homologous erythromycin, kanamycin, and streptomycin resistance determinants among group D streptococci of human and animal origin. Antimicrob Agents Chemother. 29:1986;549-555.
40. Leclercq R., Derlot E., Duval J., Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med. 319:1988;157-161.
41. Leclercq R., Courvalin P. Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrob Agents Chemother. 35:1991;1267-1272.
42. Levy S.B., McMurry L.M., Burdett V., Courvalin P., Hillen W., Roberts M.C., Taylor D.E. Nomenclature for tetracycline resistance determinants. Antimicrob Agents Chemother. 33:1989;1373-1374.
43. Marchese A., Debbia E.A., Bacca D., Balistreri G., Musolino B., Schito G.C. Multidrug-resistant Gram-positive pathogens. An update on current microbiological patterns. Drugs. 54:1997;11-20.
44. Mederski-Samoraj B.D., Murray B.E. High-level resistance to gentamicin in clinical isolates of enterococci. J Infect Dis. 147:1983;751-757.
45. McNamara E.B., King E.M., Smyth E.G. A survey of antimicrobial susceptibility of clinical isolates of Enterococcus spp. from Irish hospitals. J Antimicrob Chemother. 35:1995;185-189.
46. Melo-Cristino J. Antimicrobial resistance in staphylococci and enterococci in 10 Portuguese hospitals in 1996 and 1997. POSGAR Portuguese Study Group of Antimicrobial Resistance Microb Drug Resist. 4:1998;319-324.
47. Moellering R.C. The enterococci an enigma and a continuing therapeutic challenge . Eur J Clin Microbiol Infect Dis. 9:1990;73-74.
48. Moellering R.C. Emergence of enterococcus as a significant pathogen. Clin Infect Dis. 14:1992;1173-1178.
49. Murray B.E. The life and times of the enterococcus. Clin Microbiol Rev. 3:1990;46-65.
50. Murray B.E. New aspects of antimicrobial resistance and the resulting therapeutic dilemmas. J Infect Dis. 163:1991;1184-1194.
51. Murray B.E., Mederski-Samaroj B. Transferable β-lactamase. A new mechanism for in vitro penicillin resistance in Streptococcus faecalis. J Clin Invest. 72:1983;1168-1171.
52. Nachamkin E., Axelrod P., Talbot G.H., Fascher S.H., Wennersten C.B., Moellering R.C. Jr, MacGregor R.R. Multiply high-level aminoglycoside-resistant enterococci isolated from patients in a university hospital. J Clin Microbiol. 26:1988;1287-1291.
53. National Committee for Clinical Laboratory Standards (NCCLS) (1997). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard M7-A4. Villanova, Pa: NCCLS.
54. Pepper K., Le Bouguénec C., de Cespédès G., Horaud T. Dispersal of a plasmid-borne chloramphenicol resistance gene in streptococcal and enterococcal plasmids. Plasmid. 16:1986;195-203.
55. Pepper K., Horaud T., Le Bouguenec C., de Cespedes G. Location of antibiotic resistance markers in clinical isolates of Enterococcus faecalis with similar antibiotypes. Antimicrob Agents Chemother. 31:1987;1394-1402.
56. Pesce A., Debbia E.A., Toni M., Schito G.C. Antibiotic resistance of clinical isolates of Enterococcus in Italy. Clin Infect Dis. 15:1992;490-494.
57. Rice L.B., Messer J.W., Johnson C.H., Reasoner D.J. Occurrence of high-level aminoglycoside resistance in environmental isolates of enterococci. Appl Environ Microbiol. 61:1995;374-376.
58. Rice L.B. Tn916 family conjugative transposons and dissemination of antimicrobial resistance determinants. Antimicrob Agents Chemother. 42:1998;1871-1877.
59. Rice L.B., Carias L.L. Transfer of Tn5385, a composite, multiresistance chromosomal element from Enterococcus faecalis. J Bacteriol. 180:1998;714-721.
60. Roberts M.C. Tetracycline resistance determinants mechanisms of action, regulation of expression, genetic mobility, and distribution . FEMS Microbiol Rev. 19:1995;1-24.
61. Robinson I.M., Whipp S.C., Bucklin J.A., Allison M.J. Characterization of predominant bacteria from the colons of normal and dysenteric pigs. Appl Environ Microbiol. 48:1984;964-969.
62. Rollins L.D., Lee L.N., LeBlanc D.J. Evidence for a disseminated erythromycin resistance determinant mediated by Tn 917-like sequences among group D streptococci isolated from pigs, chickens, and humans. Antimicrob Agents Chemother. 27:1985;439-444.
63. Salminen, S., Isolauri, E., & Onnela, T. (1995). Gut flora in normal and disordered states. Chemotherapy 41 Suppl 1: 5-15.
64. Schaberg D.R., Culver D.H., Gayes R.P. Major trends in the microbial etiology of nosocomial infection. Am J Med. 91:1991;72-76.
65. Shaw, J. H., & Clewell, D. B. (1985). Complete nucleotide sequence of macrolide-lincosamide-streptogramin B-resistance transposon Tn 917 in Streptococcus faecalis. J Bacteriol1, 64, 782-796.
66. Sifuentes-Osornio J., Ponce-de-León A., Muñoz-Trejo T., Villalobos-Zapata Y., Ontiveros-Rodríguez C., Gómez-Roldán C. Antimicrobial susceptibility patterns and high-level gentamicin resistance among enterococci isolated in a Mexican tertiary care center. Rev Invest Clin. 48:1996;91-96.
67. Silverman J., Thal L.A., Perri M.B., Bostic G., Zervos M.J. Epidemiologic evaluation of antimicrobial resistance in community-acquired enterococci. J Clin Microbiol. 36:1998;830-832.
68. Simonsen G.S., Haaheim H., Dahl K.H., Kruse H., Lovseth A., Olsvik Ö., Sundsfjord A. Transmission of VanA-type vancomycin-resistant enterococci and vanA resistance elements between chicken and humans at avoparcin-exposed farms. Microb Drug Resist. 4:1998;313-318.
69. Spera R.V., Farber B.F. Multidrug-resistant Enterococcus faecium. An untreatable nosocomial pathogen. Drugs. 48:1994;678-688.
70. Taylor S.L., Pottumarthy S., Wong C.G.S., Bremner D.A., Morris A.J. Surveillance for antimicrobial resistance in enterococci. NZ Med J. 110:1997;251-253.
71. Thal L.A., Chow J.W., Mahayni R., Bonilla H., Perri M.B., Donabedian S.A., Silverman J., Taber S., Zervos M.J. Characterization of antimicrobial resistance in enterococci of animal origin. Antimicrob Agents Chemother. 39:1995;2112-2115.
72. Toala P., McDonald A., Wilcox C., Finland M. Susceptibility of group D Streptococcus (Enterococcus) to 21 antibiotics in vitro, with special reference to species differences. Am J Med Sci. 258:1969;416430.
73. Tofte R.W., Solliday J., Crossley K.B. Susceptibility of enterococci to twelve antibiotics. Antimicrob Agents Chemother. 25:1984;532-533.
74. Trieu-Cuot P., de Cespedes G., Bentorcha F., Delbos F., Gaspar E., Horaud T. Study of heterogeneity of chloramphenicol acetyltransferase (CAT) genes in streptococci and enterococci by polymerase chain reaction (PCR) characterization of a new CAT determinant . Antimicrob Agents Chemother. 37:1993;2593-2598.
75. Vandamme P., Vercauteren E., Lammens C., Pensart N., Ieven M., Pot B., Leclercq R., Goossens H. Survey of enterococcal susceptibility patterns in Belgium. J Clin Microbiol. 34:1996;2572-2576.
76. Wegener H.C., Madsen M., Nielsen N., Aarestrup F.M. Isolation of vancomycin resistant Enterococcus faecium from food. Int J Food Microbiol. 35:1997;57-66.
77. Weisblum B. Erythromycin resistance by ribosome modification. Antimicrob Agents Chemother. 39:1995;577-585.
78. Williams, J. D., Maskell, J. P., Whiley, A. C., & Sefton, A. M. (1997). Comparative in-vitro activity of quinupristin/dalfopristin against Enterococcus spp. J Antimicrob Chemother 39 Suppl A: 41-46.
79. Witte W. Impact of antibiotic use in animal feeding on resistance of bacterial pathogens in humans. Ciba Found Symp. 207:1997;61-71.
80. Zilhao R., Papadopoulou B., Courvalin P. Occurrence of the Campylobacter resistance gene tetO in Enterococcus and Streptococcus spp. Antimicrob Agents Chemother. 32:1988;1793-1796.